Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura. 2006

Feng Zhang, and Xiaoxia Chu, and Lin Wang, and Yuanyuan Zhu, and Lizhen Li, and Daoxin Ma, and Jun Peng, and Ming Hou
Hematology Oncology Center, Qilu Hospital of Shandong University, Jinan, Shandong, China.

OBJECTIVE Investigate the contribution and mechanism of cell-mediated cytotoxicity to the pathogenesis of idiopathic thrombocytopenic purpura (ITP). METHODS We observed the cytotoxic effect of cytotoxic T-lymphocyte (CTL) (CD8+) and natural killer cells (CD3- CD16+ CD56+) toward chronic ITP patient's autologous platelets, and investigated the expression of Fas ligand (FasL), tumor necrosis factor (TNF)-alpha and TNF-related apoptosis inducing ligand, as well as perforin and granzyme B mRNA in CD8+ cells using flow cytometry and reverse transcriptase-polymerase chain reaction. RESULTS We found that platelet lysis was seen only using purified CD8+ T cells as effector cells; expression of FasL and TNF-alpha in CD8+ T cells in ITP group was elevated. Moreover, the mRNA levels of granzyme B and perforin in CD8+ cells of ITP patients were increased. CONCLUSIONS Our findings suggest that CTLs are activated in chronic ITP and might be involved in the pathogenesis of this disorder. Apoptosis and perforin/granzyme-mediated cytotoxicity constitute an important pathway through which CTLs destruct autologous platelets. CTLs might be a reasonable target for a therapeutic strategy.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Feng Zhang, and Xiaoxia Chu, and Lin Wang, and Yuanyuan Zhu, and Lizhen Li, and Daoxin Ma, and Jun Peng, and Ming Hou
November 2005, Zhonghua yi xue za zhi,
Feng Zhang, and Xiaoxia Chu, and Lin Wang, and Yuanyuan Zhu, and Lizhen Li, and Daoxin Ma, and Jun Peng, and Ming Hou
September 2003, Nature medicine,
Feng Zhang, and Xiaoxia Chu, and Lin Wang, and Yuanyuan Zhu, and Lizhen Li, and Daoxin Ma, and Jun Peng, and Ming Hou
July 1968, Bulletin of the Calcutta School of Tropical Medicine,
Feng Zhang, and Xiaoxia Chu, and Lin Wang, and Yuanyuan Zhu, and Lizhen Li, and Daoxin Ma, and Jun Peng, and Ming Hou
November 2001, Medical hypotheses,
Feng Zhang, and Xiaoxia Chu, and Lin Wang, and Yuanyuan Zhu, and Lizhen Li, and Daoxin Ma, and Jun Peng, and Ming Hou
November 2002, Wiener klinische Wochenschrift,
Feng Zhang, and Xiaoxia Chu, and Lin Wang, and Yuanyuan Zhu, and Lizhen Li, and Daoxin Ma, and Jun Peng, and Ming Hou
August 1983, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Feng Zhang, and Xiaoxia Chu, and Lin Wang, and Yuanyuan Zhu, and Lizhen Li, and Daoxin Ma, and Jun Peng, and Ming Hou
January 1972, Lancet (London, England),
Feng Zhang, and Xiaoxia Chu, and Lin Wang, and Yuanyuan Zhu, and Lizhen Li, and Daoxin Ma, and Jun Peng, and Ming Hou
May 1981, British medical journal (Clinical research ed.),
Feng Zhang, and Xiaoxia Chu, and Lin Wang, and Yuanyuan Zhu, and Lizhen Li, and Daoxin Ma, and Jun Peng, and Ming Hou
March 1995, The New England journal of medicine,
Feng Zhang, and Xiaoxia Chu, and Lin Wang, and Yuanyuan Zhu, and Lizhen Li, and Daoxin Ma, and Jun Peng, and Ming Hou
March 1995, The New England journal of medicine,
Copied contents to your clipboard!